MA55958A - Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris - Google Patents

Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris

Info

Publication number
MA55958A
MA55958A MA055958A MA55958A MA55958A MA 55958 A MA55958 A MA 55958A MA 055958 A MA055958 A MA 055958A MA 55958 A MA55958 A MA 55958A MA 55958 A MA55958 A MA 55958A
Authority
MA
Morocco
Prior art keywords
ibrexafungerp
decolonization
antifungal agents
candida auris
auris
Prior art date
Application number
MA055958A
Other languages
English (en)
French (fr)
Inventor
Gonzalez David A Angulo
Stephen Andrew Barat
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of MA55958A publication Critical patent/MA55958A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
MA055958A 2019-05-16 2020-05-12 Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris MA55958A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962849019P 2019-05-16 2019-05-16

Publications (1)

Publication Number Publication Date
MA55958A true MA55958A (fr) 2022-03-23

Family

ID=70861571

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055958A MA55958A (fr) 2019-05-16 2020-05-12 Agents antifongiques, tels que l'ibrexafungerp pour la décolonisation de candida auris

Country Status (14)

Country Link
US (1) US20220211684A1 (cg-RX-API-DMAC7.html)
EP (1) EP3968986A1 (cg-RX-API-DMAC7.html)
JP (2) JP7770191B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220009416A (cg-RX-API-DMAC7.html)
CN (1) CN113905733A (cg-RX-API-DMAC7.html)
AU (1) AU2020276595B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021022876A2 (cg-RX-API-DMAC7.html)
CA (1) CA3140637A1 (cg-RX-API-DMAC7.html)
EA (1) EA202193146A1 (cg-RX-API-DMAC7.html)
IL (1) IL288165B2 (cg-RX-API-DMAC7.html)
MA (1) MA55958A (cg-RX-API-DMAC7.html)
MX (1) MX2021013899A (cg-RX-API-DMAC7.html)
TW (2) TW202602460A (cg-RX-API-DMAC7.html)
WO (1) WO2020232037A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102980640B1 (ko) 2023-07-03 2026-06-24 연세대학교 산학협력단 칸디다 아우리스에 대한 항진균제 스크리닝 방법 및 항진균용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
ES2955711T3 (es) * 2016-03-16 2023-12-05 Cidara Therapeutics Inc Regímenes de dosificación para el tratamiento de infecciones fúngicas
JP7263313B2 (ja) * 2017-04-10 2023-04-24 サイネクシス,インコーポレーテッド 併用される抗真菌剤
WO2018213641A1 (en) * 2017-05-17 2018-11-22 T2 Biosystems, Inc. Nmr methods and systems for the rapid detection of candida species
PL3661503T3 (pl) * 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Also Published As

Publication number Publication date
MX2021013899A (es) 2022-02-10
IL288165B1 (en) 2026-01-01
JP7770191B2 (ja) 2025-11-14
EA202193146A1 (ru) 2022-02-11
BR112021022876A2 (pt) 2022-04-12
TWI881977B (zh) 2025-05-01
IL288165A (en) 2022-01-01
WO2020232037A1 (en) 2020-11-19
JP2022532734A (ja) 2022-07-19
CN113905733A (zh) 2022-01-07
IL288165B2 (en) 2026-05-01
AU2020276595B2 (en) 2025-12-04
JP2025118765A (ja) 2025-08-13
TW202110441A (zh) 2021-03-16
CA3140637A1 (en) 2020-11-19
AU2020276595A1 (en) 2021-12-09
TW202602460A (zh) 2026-01-16
US20220211684A1 (en) 2022-07-07
EP3968986A1 (en) 2022-03-23
KR20220009416A (ko) 2022-01-24

Similar Documents

Publication Publication Date Title
IL288423A (en) Cannabinoid formulations
EP3833739A4 (en) AKKOMANSIA MUCINIPHILA
EP3465554A4 (en) PERSONALIZED CHATBOTS FOR PRISONERS
EP3982105A4 (en) BALANCE ADJUSTMENT PROCEDURE FOR LIFT
CL2021002592A1 (es) Composiciones fungicidas.
CL2017002883A1 (es) Derivados de 2-(feniloxi o feniltio)pirimidina como herbicidas
EP3853365A4 (en) MODULATORS OF PNPLA3 EXPRESSION
MA50406B1 (fr) Inhibiteurs pyrazole de magl
MA53924A (fr) Modulateurs de l'expression d'apol1
MA51677A (fr) Méthodes de traitement du cancer à l'aide d'anticorps anti-pd-1
EP3823978A4 (en) Fcrn antibody compositions
MA47469A (fr) Dérivés 2-(3-(1h-benzo[d]imidazol-1-yl)propyl)pipéridin-3-ol et composés similaires en tant q'inhibiteurs prs pour le traitement du cancer
EP3934466A4 (en) UNDERWEAR FOR MEN
EP3950905A4 (en) LUBRICATION OIL COMPOSITION
MA52154A (fr) Composition pharmaceutique pour l'anémie
MA55218A (fr) Eskétamine pour le traitement de la dépression
EP3937845A4 (en) INDICATOR MARKING TECHNOLOGIES FOR TEXTILES
EP3950896A4 (en) LUBRICATION OIL COMPOSITION
EP3888715A4 (en) COMPOSITION FOR TRANSPLANTATION OF AN ORGANOID
EP4083173A4 (en) LUBRICATING OIL COMPOSITION
JP1790464S (ja) 点眼器
MA41809A (fr) Biotine pour le traitement de la sclérose latérale amyotrophique
EP4017973A4 (en) BIOSYNTHESIS OF ERIODICTYOL
EP3654763A4 (en) PLANT PROMOTER FOR TRANSGENIC EXPRESSION
EP3831381A4 (en) SOLID DISPERSION OF A HYDANTOIND DERIVATIVE